返回 Agenda
Session 4: Regulatory Procedures of Drug Marketing Authorizations in the EU
Session Chair(s)
Diptee A. Gajjar, PhD
Intercontinental Regulatory Strategy Lead
Bristol-Myers Squibb Company, United States
- Centralized Procedure (CP)
- Decentralized Procedure (DCP)
- Mutual Recognition Procedure (MRP)
- National procedure
- Potential serious risk to public health